A detailed history of Capital Performance Advisors LLP transactions in Twist Bioscience Corp stock. As of the latest transaction made, Capital Performance Advisors LLP holds 150 shares of TWST stock, worth $6,237. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150
Holding current value
$6,237
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$36.72 - $58.88 $5,508 - $8,832
150 New
150 $6,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.34B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Capital Performance Advisors LLP Portfolio

Follow Capital Performance Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Performance Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Capital Performance Advisors LLP with notifications on news.